These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

193 related items for PubMed ID: 2761916

  • 1. CA 125, NB/70K, and lipid-associated sialic acid in monitoring uterine papillary serous carcinoma.
    Tseng PC, Sprance HE, Carcangiu ML, Chambers JT, Schwartz PE.
    Obstet Gynecol; 1989 Sep; 74(3 Pt 1):384-7. PubMed ID: 2761916
    [Abstract] [Full Text] [Related]

  • 2. Plasma lipid-associated sialic acid and serum CA 125 as indicators of disease status with advanced ovarian cancer.
    Vardi JR, Tadros GH, Foemmel R, Shebes M.
    Obstet Gynecol; 1989 Sep; 74(3 Pt 1):379-83. PubMed ID: 2761915
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Tumor markers CA 125, squamous cell carcinoma antigen, and carcinoembryonic antigen in patients with adenocarcinoma of the uterine cervix.
    Duk JM, Aalders JG, Fleuren GJ, Krans M, De Bruijn HW.
    Obstet Gynecol; 1989 Apr; 73(4):661-8. PubMed ID: 2648225
    [Abstract] [Full Text] [Related]

  • 6. [Serum lipid-associated sialic acid (LSA) in diagnosing and monitoring ovarian cancer].
    Yue K, Bian M, Zhu D, Liu W, Siu S.
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1995 Apr; 17(2):128-32. PubMed ID: 7656393
    [Abstract] [Full Text] [Related]

  • 7. Serial serum CA 125 measurements for evaluation of recurrence in patients with endometrial carcinoma.
    Rose PG, Sommers RM, Reale FR, Hunter RE, Fournier L, Nelson BE.
    Obstet Gynecol; 1994 Jul; 84(1):12-6. PubMed ID: 8008305
    [Abstract] [Full Text] [Related]

  • 8. Extended surgical staging for uterine papillary serous carcinoma: survival outcome of locoregional (Stage I-III) disease.
    Bristow RE, Asrari F, Trimble EL, Montz FJ.
    Gynecol Oncol; 2001 May; 81(2):279-86. PubMed ID: 11330963
    [Abstract] [Full Text] [Related]

  • 9. Comparison of three tumor markers--CA-125, lipid-associated sialic acid (LSA), and NB/70K--in monitoring ovarian cancer.
    Petru E, Sevin BU, Averette HE, Koechli OR, Perras JP, Hilsenbeck S.
    Gynecol Oncol; 1990 Aug; 38(2):181-6. PubMed ID: 2387533
    [Abstract] [Full Text] [Related]

  • 10. [Preoperative levels of CA 125 and risk factors in adenocarcinoma of the endometrium].
    Marcello C, Corda F, Pilloni MD, Puligheddu P, Lecca U.
    Ann Ostet Ginecol Med Perinat; 1989 Aug; 110(6):290-5. PubMed ID: 2639616
    [Abstract] [Full Text] [Related]

  • 11. Serum CA-15.3 and CEA patterns in postsurgical follow-up, and in monitoring clinical course of metastatic cancer in patients with breast carcinoma.
    al-Jarallah MA, Behbehani AE, el-Nass SA, Temim L, Ebraheem AK, Ali MA, Szymendera JJ.
    Eur J Surg Oncol; 1993 Feb; 19(1):74-9. PubMed ID: 8436243
    [Abstract] [Full Text] [Related]

  • 12. A comparative study of mucin-like carcinoma-associated antigen (MCA), CA 125, CA 19-9 and CEA in patients with ovarian cancer.
    Koelbl H, Schieder K, Neunteufel W, Bieglmayer C.
    Neoplasma; 1989 Feb; 36(4):473-8. PubMed ID: 2770933
    [Abstract] [Full Text] [Related]

  • 13. Monitoring endometrial adenocarcinoma with a four tumor marker combination. CA 125, squamous cell carcinoma antigen, CA 19.9 and CA 15.3.
    Matorras R, Rodríguez-Escuderoi FJ, Diez J, Genollá J, Cruz Fombellida J, Ruibal A.
    Acta Obstet Gynecol Scand; 1992 Aug; 71(6):458-64. PubMed ID: 1326844
    [Abstract] [Full Text] [Related]

  • 14. Correlation of serum sialic acid fractions as markers for carcinoma of the uterine cervix.
    Lagana A, Martinez BP, Marino A, Fago G, Bizzarri M.
    Anticancer Res; 1995 Aug; 15(5B):2341-6. PubMed ID: 8572649
    [Abstract] [Full Text] [Related]

  • 15. [Tumor markers in the monitoring of ovarian cancer].
    Xu SX.
    Zhonghua Fu Chan Ke Za Zhi; 1990 Nov; 25(6):345-7, 383. PubMed ID: 2282861
    [Abstract] [Full Text] [Related]

  • 16. Role of Ca 125 as tumor marker in ovarian carcinoma.
    Krebs HB, Goplerud DR, Kilpatrick SJ, Myers MB, Hunt A.
    Obstet Gynecol; 1986 Apr; 67(4):473-7. PubMed ID: 3008052
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.